SEC Form 4 · accession 0001209191-18-036806
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lilian Shackelford Murray
Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (right to buy)F1 | $10.80 | Jun 6, 2018 | A | 6,408 | A | — | Jun 6, 2028 | Common Stock | 6,408 | 6,408 | D |
Explanation of responses
- F1The option vests in three equal installments occurring on the first, second and third anniversary of the date of grant.